Suppr超能文献

在对干扰素治疗获得持续病毒学应答21年后,一名慢性丙型肝炎患者发生肝细胞癌

Development of Hepatocellular Carcinoma in a Patient with Chronic Hepatitis C 21 Years after Achieving a Sustained Virological Response to Interferon Therapy.

作者信息

Hara Tasuku, Ohara Tomoya, Taniguchi Masashi, Sakai Toshiaki, Oka Kohei, Iwai Naoto, Tsuji Toshifumi, Okuda Takashi, Komaki Toshiyuki, Sakagami Junichi, Kagawa Keizo

机构信息

Department of Gastroenterology and Hepatology, Fukuchiyama City Hospital, Atsunaka-chou 231, Fukuchiyama, Kyoto 620-8505, Japan.

出版信息

Case Reports Hepatol. 2020 Oct 14;2020:8824974. doi: 10.1155/2020/8824974. eCollection 2020.

Abstract

A 77-year-old man with chronic hepatitis C (CH-C) infection, who achieved a sustained virological response (SVR) to interferon (IFN) therapy, was followed up regularly. Before IFN therapy, he did not have metabolic diseases, and the histological diagnosis of his chronic hepatitis was stage-3 fibrosis. After achieving SVR, the fibrosis-4 (FIB-4) index level dropped once but gradually increased. 21 years after SVR, hepatocellular carcinoma (HCC) was diagnosed by dynamic computed tomography. The HCC was 12 mm in diameter. The HCC was treated with radiofrequency ablation. CH-C patients with advanced fibrosis require long-term follow-up, even after achieving SVR.

摘要

一名77岁的慢性丙型肝炎(CH-C)感染男性,对干扰素(IFN)治疗获得了持续病毒学应答(SVR),并接受了定期随访。在IFN治疗前,他没有代谢性疾病,其慢性肝炎的组织学诊断为3期纤维化。在实现SVR后,纤维化-4(FIB-4)指数水平一度下降,但随后逐渐升高。在SVR 21年后,通过动态计算机断层扫描诊断出肝细胞癌(HCC)。该HCC直径为12毫米。采用射频消融术对该HCC进行了治疗。即使在实现SVR后,晚期纤维化的CH-C患者仍需要长期随访。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0a5/7582091/a8ad79942747/CRIHEP2020-8824974.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验